Three-year history of transcription-mediated amplification-based Trichomonas vaginalis analyte-specific reagent testing in a subacute care patient population

Journal of Clinical Microbiology

Volumn 49, Issue 12, 2011, Pages 4190-4194

  Napierala, Maureen ^a   Munson, Erik ^a,b   Munson, Kimber L ^a   Kramme, Timothy ^a   Miller, Cheryl ^a   Burtch, Jason ^a   Olson, Robin ^a   Hryciuk, Jeanne E ^a  

^a Wheaton Franciscan Laboratory   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL RNA;

ANALYTICAL PARAMETERS; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; COMMUNITY CARE; CONTROLLED STUDY; DIAGNOSTIC KIT; EMERGENCY PHYSICIAN; FEMALE; FEMALE GENITAL TRACT CYTOLOGY; GENE AMPLIFICATION; HUMAN; MALE; MEDICAL AUDIT; MOLECULAR DIAGNOSIS; MOLECULAR PROBE; NEISSERIA GONORRHOEAE; NONHUMAN; PARASITE IDENTIFICATION; PRIORITY JOURNAL; RELATIVE LIGHT UNIT; SEX RATIO; SEXUALLY TRANSMITTED DISEASE; TRANSCRIPTION MEDIATED AMPLIFICATION; TREND STUDY; TRICHOMONAS VAGINALIS; URETHRA; URINALYSIS; URINE CULTURE; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR;

CHLAMYDIA TRACHOMATIS; FEMALE; GENITALIA, FEMALE; HUMANS; MALE; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; NEISSERIA GONORRHOEAE; PARASITOLOGY; PREVALENCE; SUBACUTE CARE; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; URETHRA; URINE;

EID: 82455185082     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05632-11     Document Type: Article

References (33)

1. Andrea, S. B., and K. C. Chapin. 2011. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications. J. Clin. Microbiol. 49:866-869.
2. Borchardt, K. A., S. al-Haraci, and N. Maida. 1995. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin. Med. 71:405-406.
3. Cates, W., and The American Social Health Association Panel. 1999. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex. Transm. Dis. 26:S2-S7.
4. Centers for Disease Control and Prevention. 2008. Sexually transmitted disease surveillance, 2007. U.S. Department of Health and Human Services, Atlanta, GA.
5. Chernesky, M., et al. 2006. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J. Clin. Microbiol. 44:400-405.
6. Comanor, L., et al. 2001. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. Am. J. Gastroenterol. 96:2968-2972. (Pubitemid 32959541)
7. Cotch, M. F., et al. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360. (Pubitemid 27306585)
8. Ferris, D. G., et al. 1995. Physician office laboratory education and training in primary care residency programs. Arch. Fam. Med. 4:34-39.
9. Garber, G. E. 2005. The laboratory diagnosis of Trichomonas vaginalis. Can. J. Infect. Dis. Med. Microbiol. 16:35-38. (Pubitemid 40470553)
10. Gaydos, C. A., et al. 2003. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 41:304-309. (Pubitemid 36098592)
11. Gaydos, C. A., M. Theodore, N. Dalesio, B. J. Wood, and T. C. Quinn. 2004. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J. Clin. Microbiol. 42:3041-3045. (Pubitemid 38938055)
12. Hardick, A., J. Hardick, B. J. Wood, and C. Gaydos. 2006. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol. 44:4197-4199. (Pubitemid 44737270)
13. Heine, P., and J. A. McGregor. 1993. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 36:137-144. (Pubitemid 23065139)
14. Hobbs, M. M., et al. 1999. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Transm. Dis. 26:381-387. (Pubitemid 29372769)
15. Huppert, J. S., et al. 2010. Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians. Sex. Transm. Infect. 86:514-519.
16. Huppert, J. S., et al. 2007. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of T. vaginalis in young women. Clin. Infect. Dis. 45:194-198. (Pubitemid 47041010)
17. Ikeda-Dantsuji, Y., I. Konomi, and A. Nagayama. 2005. In vitro assessment of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis using highly purified elementary bodies. J. Med. Microbiol. 54:357-360. (Pubitemid 40489541)
18. Johnston, V. J., and D. C. Mabey. 2008. Global epidemiology and control of Trichomonas vaginalis. Curr. Opin. Infect. Dis. 21:56-64.
19. Laga, M., et al. 1993. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95-102. (Pubitemid 23069039)
20. Lawing, L. F., S. R. Hedges, and J. R. Schwebke. 2000. Detection of trichomoniasis in vaginal and urine specimens from women by culture and PCR. J. Clin. Microbiol. 38:3585-3588.
21. Levett, P. N., et al. 2008. Evaluation of three automated nucleic acid amplification systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens. J. Clin. Microbiol. 46:2109-2111. (Pubitemid 351831856)
22. Levine, W. C., et al. 1998. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J. Infect. Dis. 177:167-174. (Pubitemid 28030448)
23. Munson, E., et al. 2010. Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions. Diagn. Microbiol. Infect. Dis. 68:66-72.
24. Munson, E., et al. 2008. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 46:3368-3374.
25. Nye, M. B., J. R. Schwebke, and B. A. Body. 2009. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol. 200:188.e1-188.e7.
26. Sarrazin, C., G. Teuber, R. Kokka, H. Rabenau, and S. Zeuzem. 2000. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology 32:818-823.
27. Schwebke, J. R., et al. 2011. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J. Clin. Microbiol. [Epub ahead of print.]
28. Schwebke, J. R., and E. W. III. Hook. 2003. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J. Infect. Dis. 188:465-468. (Pubitemid 36960659)
29. Steindel, S. J., et al. 2002. Practice patterns of testing waived under the Clinical Laboratory Improvement Amendments. Arch. Pathol. Lab. Med. 126:1471-1479. (Pubitemid 36237253)
30. Stull, T. M., T. L. Hearn, J. S. Hancock, J. H. Handsfield, and C. Collins. 1998. Variation in proficiency testing performance by testing site. JAMA 279:463-468.
31. Sutton, M., et al. 2007. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin. Infect. Dis. 45:1319-1326. (Pubitemid 351411908)
32. Weinstock, H., S. Berman, and W. Cates, Jr. 2004. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect. Sex. Reprod. Health 36:6-10. (Pubitemid 38258322)
33. Wendel, K. A., E. J. Erbelding, C. A. Gaydos, and A. M. Rompalo. 2003. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex. Transm. Infect. 79:151-153. (Pubitemid 36469623)